about
Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisHepatitis B virus inhibits apolipoprotein A5 expression through its core geneNotch Signaling Contributes to Liver Inflammation by Regulation of Interleukin-22-Producing Cells in Hepatitis B Virus Infection.Treatment of chronic hepatitis B infection-2017.Hepatitis A to E: what's new?Epigenetic Regulation of Hepatitis B Virus Covalently Closed Circular DNA: Implications for Epigenetic Therapy against Chronic Hepatitis B.The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing.
P2860
Q28074434-8AA19C97-F95C-45E5-A4DF-51782E248FA9Q28597775-2385274F-8114-4662-8E51-8D7B1E8090AAQ37342493-4CCB4D91-CDAE-4172-9A35-13F15715B491Q39067365-3E7DDAC4-1201-4884-9942-E6EF620C8162Q39237214-2484803F-A792-4CA4-AD52-71E69CA0636DQ40073818-C27FCBE1-FD0C-46BE-AA71-CFE5A87994AFQ46490867-C02ADB7E-189C-446E-8ED3-EF72CFDE4D44
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
New therapies for chronic hepatitis B.
@en
type
label
New therapies for chronic hepatitis B.
@en
prefLabel
New therapies for chronic hepatitis B.
@en
P2860
P356
P1433
P1476
New therapies for chronic hepatitis B
@en
P2093
Maya Bitton Alaluf
P2860
P304
P356
10.1111/LIV.13086
P50
P577
2016-03-14T00:00:00Z